Doha E Ellakwa

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 3

Top Topics

Small Cell Lung Cancer

Molecular Docking

Tyrosine Kinase

Cell Cycle Arrest

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Belgin Sever, Mehlika Dilek Altintop, Ahmet Özdemir, Gülşen Akalın Çiftçi, Doha E Ellakwa, Hiroshi Tateishi, Mohamed Osman Radwan, Mahmoud A A Ibrahim, Masami Otsuka, Mikako Fujita, Halilibrahim Çiftçi, Taha Farouk Shehata Ali
In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors. Molecules (Basel, Switzerland) 25 (21) (2020)
Halilibrahim Çiftçi, Mohamed Osman Radwan, Safiye E Ozturk, N Gokce Ulusoy, Ece Sozer, Doha E Ellakwa, Zeynep Ocak, Mustafa Can, Taha F S Ali, Howaida I Abd-Alla, Nurettin Yayli, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita
Design, Synthesis and Biological Evaluation of Pentacyclic Triterpene Derivatives: Optimization of Anti-ABL Kinase Activity. Molecules (Basel, Switzerland) 24 (19) (2019)
Mohamed Osman Radwan, Halilibrahim Çiftçi, Taha F S Ali, Doha E Ellakwa, Ryoko Koga, Hiroshi Tateishi, Akiko Nakata, Akihiro Ito, Minoru Yoshida, Yoshinari Okamoto, Mikako Fujita, Masami Otsuka
Antiproliferative S-Trityl-l-Cysteine -Derived Compounds as SIRT2 Inhibitors: Repurposing and Solubility Enhancement. Molecules (Basel, Switzerland) 24 (18) (2019)